Robert Roškar

university of ljubljana

H指数:23

被引数:1,889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ascorbic Acid and Its Hydrophilic Derivatives in Commercial Cosmetics: A Cross-Sectional Study of Their Quality Control and Stability

维生素C及其亲水衍生物在商业化妆品中的应用：对其质量控制与稳定性的横断面研究

Cosmetics

IF3.2

2026-08-040

食品补充剂中的维生素相关N-亚硝胺：基于高灵敏度LC-HRMS的全面评估

LWT-Food Science and Technology

IF6.6

2026-08-010

OAAI

Extractables and Leachables in Pharmaceutical Products: Potential Adverse Effects and Toxicological Risk Assessment

Toxics

IF4.1

2026-01-200

OAAI

Development and validation of an LC-MS/MS bioanalytical method for simultaneous determination of five main metabolites from the folate-methionine cycle in biological samples: Implications for anti-folate treatment

LC-MS/MS生物分析方法的开发与验证：用于同时测定生物样本中叶酸-蛋氨酸循环的五种主要代谢物——抗叶酸治疗的启示

Microchemical Journal

IF5.1

2025-11-300

OAAI

Advanced analytical approach for the determination of NDELA and twelve other N-nitrosamines in cosmetic products

高级分析方法用于化妆品中NDELA及其他十二种N-亚硝胺的测定

Microchemical Journal

IF5.1

2025-09-300

OAAI

Use of Factorial Designs to Reduce Stability Studies for Parenteral Drug Products: Determination of Factor Effects via Accelerated Stability Data Analysis

利用析因设计减少注射剂产品稳定性研究：通过加速稳定性数据分析确定因子效应

Pharmaceutics 2025, Vol. 17, Page 1067

IF0

2025-08-180

PRE

NDMA in macrolides: GC-MS/MS method for its detection and study of its formation

大环内酯类药物中的NDMA：检测其并研究其形成过程的GC-MS/MS方法

European Journal of Pharmaceutical Sciences

IF4.7

2025-05-210

Additive effects of the new viscosity-reducing and stabilizing excipients for monoclonal antibody formulation

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-04-150

PRE

Exploiting the potential of in situ forming liquid crystals: development and in vitro performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration

开发和应用原位形成液晶的潜力：用于胸腺素α1皮下注射的长效 Depot 的开发及体外性能研究

DRUG DELIVERY

IF8.1

2025-03-110

Accelerated Predictive Stability Testing: Accelerating Registration Phase and Application of Reduced Designs for Shelf-Life Determination of Parenteral Drug Product

PHARMACEUTICS

IF5.5

2025-01-250

OAAI

A comprehensive approach for N-nitrosamine determination in pharmaceuticals using a novel HILIC-based solid phase extraction and LC-HRMS

TALANTA

IF6.1

2025-01-010

OAAI

Enteric Coated Pellets with Lactoferrin for Oral Delivery: Improved Shelf Life of the Product

PHARMACEUTICS

IF5.5

2024-12-260

OAAI

Proof-of-concept for removing micropollutants through a combination of sub-atmospheric-pressure non-thermal plasma and hydrodynamic (super) cavitation

ULTRASONICS SONOCHEMISTRY

IF9.7

2024-12-010

OAAI

NUTRIENTS

IF5

2024-11-130

OAAI

A Comprehensive Analytical Approach for Quality Control of Collagen in Food Supplements

MARINE DRUGS

IF5.4

2024-09-260

OAAI

Matrixing Designs for Shelf-Life Determination of Parenteral Drug Product: A Comparative Analysis of Full and Reduced Stability Testing Design

PHARMACEUTICS

IF5.5

2024-08-241

OAAI

N-Acetylcysteine Ineffective in Alleviating Hangover from Binge Drinking: A Clinical Study

TOXICS

IF4.1

2024-08-120

OAAI

The Impact of Phospholipid-Based Liquid Crystals' Microstructure on Stability and Release Profile of Ascorbyl Palmitate and Skin Performance

MOLECULES

IF4.6

2024-07-031

OAAI

The Incorporated Drug Affects the Properties of Hydrophilic Nanofibers

NANOMATERIALS

IF4.3

2024-05-282

OAAI

The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-04-014

OAAI

Robert Roškar

个人简介

教育背景

工作经历

荣誉奖项

研究方向